J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 529, Number 1, 243-262, November 15, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malm, C.
Right arrow Articles by Lundberg, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malm, C.
Right arrow Articles by Lundberg, I.
The Journal of Physiology (2000), 529.1, pp. 243-262
© Copyright 2000 The Physiological Society

Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies

Christer Malm *†, Pernilla Nyberg ‡, Marianne Engström ‡, Bertil Sjödin*, Rodica Lenkei §, Björn Ekblom *† and Ingrid Lundberg ‡

* Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, †University College of Sport and Exercise, Stockholm, ‡Department of Rheumatology, Karolinska Institutet, Stockholm and §Nova Medical Research, St Görans Hospital, Stockholm, Sweden

MS 0858 Received 15 March 2000; accepted after revision 26 July 2000.
  ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

  1. A role of the immune system in muscular adaptation to physical exercise has been suggested but data from controlled human studies are scarce. The present study investigated immunological events in human blood and skeletal muscle by immunohistochemistry and flow cytometry after eccentric cycling exercise and multiple biopsies.

  2. Immunohistochemical detection of neutrophil- (CD11b, CD15), macrophage- (CD163), satellite cell- (CD56) and IL-1beta-specific antigens increased similarly in human skeletal muscle after eccentric cycling exercise together with multiple muscle biopsies, or multiple biopsies only.

  3. Changes in immunological variables in blood and muscle were related, and monocytes and natural killer (NK) cells appeared to have governing functions over immunological events in human skeletal muscle.

  4. Delayed onset muscle soreness, serum creatine kinase activity and C-reactive protein concentration were not related to leukocyte infiltration in human skeletal muscle.

  5. Eccentric cycling and/or muscle biopsies did not result in T cell infiltration in human skeletal muscle. Modes of stress other than eccentric cycling should therefore be evaluated as a myositis model in human.

  6. Based on results from the present study, and in the light of previously published data, it appears plausible that muscular adaptation to physical exercise occurs without preceding muscle inflammation. Nevertheless, leukocytes seem important for repair, regeneration and adaptation of human skeletal muscle.
  INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

Muscular adaptation to physical stress is of significant importance for normal muscular development and function. Without stimulation from physical activity, muscle tissue will undergo atrophy and decreased functional capacity. In addition, muscular adaptation to physical exercise is indispensable for increased physical performance with training. The mechanisms responsible for maintaining normal muscle function in healthy individuals are largely unknown, as the processes involved in adapting muscle tissue to changes in functional demand have not been clarified. The involvement of several different systems, including the nervous, neuroendocrine, vascular and immune systems, is most probably inevitable (Grounds, 1991; Felten et al. 1993; Ottaway & Husband, 1994; Chambers & McDermott, 1996). Exercise, especially if strenuous and including eccentric muscle contractions, is believed to induce local muscle damage resulting in the release of various substances such as intracellular proteins, cytokines and chemokines, ultimately resulting in an inflammatory response (Shek & Shephard, 1998). This local inflammation may include complement activation, upregulation of adhesion molecule expression on leukocytes and endothelium with subsequent migration and infiltration of positively selected blood leukocytes into the affected tissue (Tidball, 1995). Suggestions have been made that the immune system may play an important role in adaptation to physical stress (Fielding & Evans, 1997), but few studies have yet been conducted to directly investigate this hypothesis. One possible explanation for the lack of investigations may be the lack of applicable analytical methods. Some of the methodological limitations have now been overcome, and numerous studies have investigated the effect of exercise on circulating blood leukocytes regarding absolute number, percentage distribution and in vitro function (Pedersen, 1997). These studies are important for understanding the systemic function of the immune system but give only limited information about local immunological events in peripheral tissue. It may be argued that leukocytes in circulation in fact represent a population of cells on their way towards participation in ongoing tissue surveillance, repair and adaptation.

Knowledge regarding the interaction between circulating and tissue leukocytes may be used as a means to understand muscular adaptation to physical exercise, the mechanisms behind the overtraining syndrome in athletes and overuse injuries in conjunction with monotonous work tasks. In a clinical setting, an inflammatory-inducing exercise model can be used in the study of inflammatory muscle diseases as well as in designing exercise protocols for the elimination of some of the disabling symptoms associated with these diseases.

The intention of this study was to perform quantitative and qualitative analysis of leukocytes in blood and quantitative analysis of leukocytes in human muscle tissue in response to exercise-induced stress. Based on current knowledge regarding the inflammatory response in tissue, a selection of common leukocyte membrane antigens believed to be involved in the exercise-induced activation of the immune system was investigated (Table 2). Cytokines can be mediators of the inflammatory response in muscle tissue, and some cytokines have previously been detected in muscle tissue from patients with chronic muscle inflammation (Lundberg et al. 1997). Thus, five different cytokines were investigated in this study (Table 2). Because the intention in this study was to investigate inflammatory events, there were concerns raised regarding the effects of multiple biopsies in the same muscle. A control group, which did not exercise, was therefore included to investigate the effects of multiple muscle biopsies on local and systemic immunological variables.

  METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Subjects

Thirteen healthy male subjects with a mean age of 23·9 years (range 19-32) and a mean body mass of 74·9 kg (range 63-95) participated in the study. All subjects were physically active on a regular basis (mean maximal oxygen uptake during concentric cycling (O2,max) = 3·66 l min-1; range 2·80-4·57). After receiving oral and written information about the study, subjects signed an informed consent and were randomly assigned to either exercise or control groups. The study conformed with the Declaration of Helsinki, and was approved by the Ethics Committee at the Karolinska Institute (Dnr: 97-044).

Exercise protocol

Not later than 2 days before the eccentric cycling exercise each subject's maximal oxygen uptake during concentric cycling was determined (Medical Graphics Corp. CPX system, St Paul, MN, USA). A standard incremental cycling test was performed, starting at a work rate of 100 W at 60 revolutions min-1 with a 50 W increase in work rate every 2 min until exhaustion. Subjects were asked not to perform any strenuous or unaccustomed exercise from 7 days before the eccentric cycling until the last muscle and blood sample was taken.

The electrically powered bicycle used in this study has previously been used for eccentric cycling exercise (Friden et al. 1983). It consists of an electrical motor, an electrical induction clutch and a modified cycle ergometer. Subjects were instructed to maintain 60 r.p.m. for 30 min at a work rate equal to the highest concentric cycling work rate maintained for 2 min during the concentric cycling O2,max test. This protocol is similar to the one used by Friden et al. (1983). The work rate was chosen after a series of pilot trials on separate subjects, where different eccentric work rates relative to the subject's concentric O2,max were tested in order to determine the highest eccentric work rate possible to maintain for 30 min. All subjects performed eccentric cycling at 250 or 300 W. In a few cases the work rate had to be decreased at the end of exercise due to extreme fatigue. The eccentric exercise can thus be considered maximal or close to maximal for most subjects, with respect to eccentric muscular exercise capacity. The O2 uptake (O2) was measured during the last 5 min of exercise, and blood lactate samples were taken 3 min post exercise.

Blood samples

Blood from a fingertip capillary was collected 3 min post testing for determination of blood lactate concentration using the YSI 2300 STAT lactate analyser (YSI Corp., Yellow Springs, OH, USA).

Immediately prior to each muscle biopsy, venous blood samples were drawn from a forearm vein before, immediately after and 6, 24 and 48 h, and 4 and 7 days post exercise. Blood samples for analysis of catecholamines were only drawn before and immediately after exercise. Five millilitre samples of blood were collected (1) into Vacutainer tubes containing ethylendiaminetetraacetic acid (EDTA; Becton Dickinson, France) for leukocyte analysis by flow cytometry, (2) into untreated Vacutainer tubes for analysis of C-reactive protein (CRP), cortisol, albumin, sex hormone-binding globulin (SHBG) and testosterone and (3) into heparinized tubes (Becton Dickinson) for catecholamine and creatine kinase (CK) analysis.

Flow cytometry

Determination of different subsets of leukocytes (Table 1 and Table 2) was accomplished by flow cytometry with three-colour analyses. The method for three-colour flow cytometry analysis has been described in detail previously (Lenkei & Andersson, 1995) and is based on a high degree of standardization.

Table 1. Antigens investigated on lymphocytes and monocytes in blood

Antigen * Function Expression
Lymphocytes
   CD3 Associated with the T cell receptor. Involved in signal transduction T cells
   CD4 Accessory molecule for TCR antigen recognition, MHC II interaction T helper cells, monocytes
   CD5 Signal transduction T cells, B and NK cell subsets
   CD8 Accessory molecule for TCR antigen recognition, MHC I interaction T cytotoxic/supressor cells
   CD11b Integrin, adhesion to vascular endothelium, receptor for C3bi Granulocytes, monocytes, NK cells, T cells
   CD16 Low affinity Fc receptor for IgG NK, monocytes, neutrophils
   CD20 Regulates B cell activation and proliferation B cells
   CD23 Triggers monokine release, pro-inflammatory, IgE synthesis B cells, monoytes
   CD45 Cytoplasmic phosphatase activity, signal transduction, apoptosis All leukocytes
   CD56 Homotypic adhesion NK cells, T cell subset, some B cells
   CD57 Neuroadhesion molecule NK cells, T cells
   CD62L Selectin, homing receptor on leukocytes Blood B, T and NK cells, monocytes, granulocytes
   DR MHC II subunit Antigen-presenting cells
Monocytes
   CD14 LPS binding protein. Activation marker. Induces oxidative burst Monocytes
* Cluster of differentiation (CD). TCR, T cell receptor; MHC, major histocompatibility complex; LPS, lipopolysaccharide.

Table 2. Staining panel for immunohistochemistry

Antigen* Clone Supplier Dilution Expression, function
CD3 T3-4B5 DP 1:400 T cells, T cell receptor accessory molecule
CD4 MT310 DP 1:100 T helper, monocytes, macrophages, all APC, MHC II binding
CD8 DK25 DP 1:100 T cytotoxic, MHC I binding
CD11b 2LPM19c DP 1:800 Granulocytes, C3bi receptor (CR3)
CD15 C3D-1 DP 1:20 Granulocytes
CD56 MOC-1 DP 1:100 NK cells, satellite cells, dendritic cells, (N-CAM)
CD79alpha JCB117 DP 1:20 B cells
CD163 Ber-MAC3 DP 1:200 Human macrophages
IL-1alpha Mix CG 1:500 Macrophages, fibroblasts, endothelial cell, smooth muscles. Pro-inflammatory effects
IL-1beta Mix CG 1:500 Macrophages, fibroblasts, endothelial cell, smooth muscles
IL-1ra Mix BMA 1:100 Blocks IL-1alpha and IL-1beta function
IL-6 AF206 RD 2 µg ml-1 Macrophages, T2 helper cells. Pro-inflammatory. (Goat polyclonal)
IL-6 MQ2-6A3 PH 2 µg ml-1 Macrophages, T2 helper cells. Pro-inflammatory. (Rat monoclonal)
TNFalpha Mab-1 PH 1:83 Macrophages. Induces cytokine production, weight-loss in chronic inflammation
Endothelium EN4 SB 1:100 Human endothelium
Neg. control IgG1 DP 1:20 Aspergillus niger glucose oxidase antibody
APC, antigen presenting cells; DP, DAKOPATTS AB, Älsvjö, Sweden; SB, SANBIO, Netherlands; PH, Pharmingen, USA; CG, Immunocontact, Ciba-Geigen, Switzerland; BMA, Biomedicals AG, Switzerland; RD, R&D Systems, UK. * Cluster of differentiation (CD). Neg. control, negative control.

White blood cell count and differentials were estimated with a Coulter STKS haemocytometer (Beckman Coulter Inc., Fullerton, CA, USA). Because cell numbers were determined in whole blood, corrections for changes in plasma volume were not made.

C-reactive protein and albumin

C-reactive protein (CRP) and albumin were analysed by means of particle-enhanced immunonephelometry (Dade Behring Marburg, Germany).

Cortisol

Total serum cortisol was determined by a standard immunofluorescent method (Department of Clinical Chemistry, Karolinska Hospital, Solna, Sweden).

Testosterone, sex hormone binding globulin (SHGB) and albumin

Serum testosterone and SHGB concentration were determined by a standard time-resolved fluoroimmunoassay (Kit B050-101 and B070-101 respectively; AutoDelphia, Wallac Oy, Finland). The biologically available (free) testosterone concentration (not bound to SHGB or albumin) was calculated as T(1 + 0·601C) where T is unbound testosterone and C is plasma albumin concentration (personal communication from Regina Solborg, Department of Clinical Chemistry, Karolinska Hospital, Solna, Sweden).

Creatine kinase

Creatine kinase (CK) activity was measured using a standard laboratory kit (CK MPR2, Boehringer-Mannheim, Germany) and a DU-70 spectrophotometer (Beckman Instruments AB, Bromma, Sweden).

Catecholamines

Adrenaline, noradrenaline and dopamine were analysed in heparinized plasma, using high-pressure liquid chromatography (HPLC) with electrochemical detection (CMA Microdialysis AB, Solna, Sweden) and a Nucleosil-100 SA 5 µm column (NC100-5SA-250D, Hichrome, Berks, UK). The coefficient of variance (n = 8) was 4·6 % for noradrenaline, 6·0 % for adrenaline and 7·4 % for dopamine.

Muscle biopsies

Muscle biopsies were taken from the vastus lateralis using the forceps biopsy technique. The first, second, fourth and sixth biopsies were taken in the left leg and the third, fifth and seventh biopsies were taken in the right leg. The first biopsy in each leg was taken in the distal part of the muscle and each subsequent biopsy was taken approximately 2 cm proximal to the previous one. This procedure was used in order to minimize the influence of one biopsy on the following one. After local epidermal anaesthesia (Carbocain 20 mg ml-1, ASTRA, Södertälje, Sweden) a 1·5 cm incision was made through the dermis, epimysium and perimysium and a 50-100 mg muscle tissue sample removed. The muscle sample was placed in Tissue-Tek medium (Miles Laboratories, Elkhart, IN, USA), frozen in isopropanol in liquid nitrogen within 1 min and stored at -70°C before sectioning (6 µm). Sections were placed on Superfrost glass slides (Novakemi AB, Enskede, Sweden), air dried overnight (leukocyte antigens) or fixed in 2 % formaldehyde and air dried for 30 min (cytokines) and stored at -70°C until staining.

Muscle samples from four subjects (two exercised and two controls) were also stained using Gomoris trichrome method for altered muscle fibres and for acid phosphatase (Department of Neurophathology, Huddinge Hospital, Sweden).

Immunhistochemistry

The Vectastain ABC Elite chemicals and rapid staining protocol were used (Vector Laboratories, Burlingame, CA, USA) when investigating expression of leukocyte phenotypic antigens with monoclonal antibodies in muscle tissue sections (Table 2). For cytokine staining, a modified Vectastain protocol was used.

Image analysis

For quantification of positively stained tissue sections, a semi-automated image analysis system was used (Leica Microsystems, Kista, Sweden). The system consists of a high resolution 3CCD camera (DXC-950P, Sony Corporation, Tokyo, Japan) mounted on a Leica Fluovert FS microscope and connected to the QWin 500IW v.2.2 image analysis system (Leica Microsystems, Kista, Sweden) via a stabilized power supply (Inmac Power Line Conditioner 8831-7, Inmac, Santa Clara, CA, USA).

Analyses were performed on three separate areas of each muscle section for a total area of approximately 1·5 mm2 per antigen and biopsy. The analyses included detection of positively stained tissue, manual counting of the total number of muscle fibres, measurement of detected area and counting of positively stained leukocyes by the QWin system. All CD antigens were detected on leukocytes only, except CD56 which was also present on satellite and muscle cells. The proportions of CD56 positive satellite and muscle cells of all muscle cells were calculated by manual counting. Because identical statistical results were obtained when using detected leukocyte number or areas, only 'area' results are presented. The detection threshold for positively stained tissue was set for each antigen using the pre-exercise biopsy and kept constant for all seven biopsies from the same subject. The optimal threshold for each individual and each antigen was determined. The coefficient of variance for repeated measurement of the same tissue section was 0·08 % (n = 39).

Muscle soreness

At the time points of blood and muscle samples, delayed onset of muscle soreness (DOMS) at rest was estimated by the subject's rating on a 0-10 subject rating scale (0 = no soreness and 10 = very, very sore).

Statistical analysis

The StatView software (Abacus Concepts, Inc., Berkeley, CA, USA) was used for all statistical analyses. Due to the abnormal distribution in resting numbers of most blood leukocyte phenotypes in a larger population (n = 57) (Lenkei & Andersson, 1995), as well as in blood and muscle samples in the present study (skewness > 2·0), non-parametric methods were used. The Mann-Whitney procedure tested for within-group changes and the Wilcoxon signed rank test was employed for between group comparisons. Non-parametric methods were also applied for investigating CK and DOMS changes. Multiple regression was used to investigate relationships between variables. A strict statistical approach was used with r2 > 0·80 accepted as significant in the model, but variables where one single outlier determined the correlation were excluded. Outliers were judged by a dependent versus a fitted plot. Two predictor variables were used only if they were not correlated to each other (P > 0·2), for example, the prediction of CD11b in muscle in the exercise group where the testosterone/cortisol quota (an indicator of metabolic stress) and eccentric O2 are not correlated (Table 8 and Fig. 1).

View larger version
[in this window]
[in a new window]

    Figure 1

    Demonstration of regenerating muscle cells (A) and activated satellite cells (B) by the expression of CD56 in human muscle tissue.

  RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Eccentric cycling exercise for 30 min resulted in significant changes in several measured variables in blood and muscle tissues. However, the procedure with multiple muscle biopsies and blood samples resulted in similar changes in control subjects (Table 3, Table 4 and Table 5). Multiple regression analysis revealed that the mechanisms causing similar changes in the exercise and control groups may or may not be the same (Table 8 and Fig 5, Fig 6, Fig 7, Fig 8, Fig 9 and Fig 10).

Eccentric exercise intensity

During the last 5 min of eccentric exercise, the subjects' O2 was 1·20 l min-1 (1·08-1·31 l min-1) (mean (95 % confidence interval)) equivalent to 37 % (31-41 %) of concentric cycling O2,max. Blood lactate 3 min post exercise was 2·6 mM (1·5-3·7 mM).

Muscle soreness, muscle damage and leukocyte phenotype

Subjects in the exercise group experienced severe delayed onset of muscle soreness (DOMS), peaking 24 or 48 h after exercise, while the control group reported no muscle soreness (Table 6). Because DOMS is a non-linear variable, the use of correlation statistics between DOMS and other measured linear variables may not be done. Grouping subjects in 'muscle soreness' and 'no muscle soreness' groups and using regression analysis resulted in a significant positive correlation between DOMS and CD4 expression on CD3+ lymphocytes post exercise (r2 = 0·61, P = 0·001). CK activity in blood, a reported marker of muscle damage (Friden et al. 1989) increased by 123 % at 24 h and CRP, a marker of systemic inflammation and tissue damage increased by 392 % 24 h after exercise (Table 6). The CK activity at 24 h post exercise was not correlated to exercise intensity (percentage O2,max; eccentric O2 (l min-1 or l min-1 kg-1)), leukocyte infiltration or other indicators of muscle damage, but was correlated positively to cortisol (at 6 h) and free testosterone (at 24 h) concentrations in both the exercised (r2 = 0·74, P = 0·029) and control (r2 = 0·97, P = 0·013) groups (both groups together r2 = 0·80, P = 0·0003). CRP was always < 10 µg min-1, but the significantly increased CRP concentration at 24 h in the exercise group correlated with CD8 expression on CD3+ lymphocytes post exercise (r2 = 0·90, P = 0·0006).

Muscle biopsies from four subjects (two exercised and two controls) stained using Gomori's trichrome procedure, which detects abnormal mitochondria, and for acid phosphatases did not show any signs of altered muscle fibres or enzyme expression. Further, in seven biopsies from one subject with severe muscle soreness, no change in desmin immunostaining was detected at any time point.

Leukocytes in blood

The total number of circulating white blood cells increased significantly in the exercise group compared to rest, peaking at 6 h and lasting for 24 h post exercise, but never differed significantly from the control group (Table 3). The increase at 6 h was mostly due to the increase in neutrophils and T (CD3+) cell numbers (r2 = 0·98, P < 0·0001).

Table 3. Significantly changed leukocyte phenotypes in blood before and after eccentric cycling exercise

Phenotype Rest Post 6 h 24 h 48 h 4 days 7 days
LPK (cells ml-1) Exercise 5200 5400*‡ 8600* 5700* 5400 5500* 5700
(4300-6300) (4600-7300) (6900-10000) (5000-7800) (3300-10900) (5000-7000) (4700-7100)
Control 5500 5600 ‡ 6900 6200 5700 5200 5500
(3500-8700) (3700-7800) (4000-9900) (4600-9500) (3400-8300) (3900-8100) (4700-6100)
Lymphocytes (cells ml-1) Exercise 1955 1998 2066 2185*‡ 1999 1978 2033
(1765-2311) (1756-2585) (1813-2669) (1937-2737) (1526-2462) (1727-2070) (1653-2403)
Control 2470 2106* 2284 2297*‡ 1772 2357* 2095
(1573-4013) (1420-3350) (1526-3399) (1374-3498) (1526-2462) (1398-3225) (1636-2282)
Lymphocytes (%) Exercise 38 34 25*dagger 35 39 34 40
(33-45) (31-43) (22-32) (30-46) (22-47) (26-40) (26-47)
Control 45 42* 34* 39* 33§ 42* 41
(42-49) (38-45) (28-45) (24-45) (24-42) (27-51) (33-51)
Neutrophils (cells µl-1) Exercise 2500 2900* 5300* 3000 2700 3000* 2600
(1800-3600) (2100-4200) (4000-6500) (2200-4400) (400-8600) (2300-4300) (1800-4400 )
Control 2200 2700 3900* 3500* 3500 2500 2400
(1500-3700) (1600-3600) (1800-5800) (2100-5500) (1700-4900) (1450-4800) (1800-3100)
Neutrophils (%) Exercise 49dagger 49 62* 52 53 53 46
(42-55) (45-56) (55-67) (43-58) (39-71) (46-60) (38-62)
Control 41 45* 57* 47* 56 49 45
(38-45) (39-51) (45-64) (41-67) (45-67) (36-64) (35-56)
Monocytes (cells µl-1) Exercise 474 564*‡ 687* 551* 440 612* 612
(288-514) (338-669) (444-1060) (356-656) (347-485) (442-683) (442-683)
Control 610 541‡ 662 800 429 598 527
(213-827) (206-748) (292-806) (282-1016) (169-769) (397-681) (283-779)
Monocytes (%) Exercise 9 9 10 8 7 11* 11
(6-10) (5-11) (6-13) (6-10) (5-9) (8-12) (8-12)
Control 9 8 8 9 9 8 10
(7-11) (7-12) (6-9) (5-13) (4-12) (7-11) (6-14)
Lymphocytes
CD3+ (cells µl-1) Exercise 1402 1252 1490 1503 1350 1272* 1433
(1326-1572) (1134-1811) (1134-2017) (1240-1910) (992-1916) (1088-1417) (1153-1668)
Control 1538 1437 1276* 1342* 1171 1608 1348
(593-3372) (670-2786) (558-2594) (439-2661) (395-2371) (651-2645) (873-2069)
CD3+ (%) Exercise 73 69 68 67 75 67* 71
(67-77) (59-76) (61-78) (56-76) (63-81) (59-73) (60-82)
Control 64 72 57 66 66 68 66
(51-85) (54-87) (44-81) (41-82) (54-83) (53-84) (56-74)
CD8+CD11b+ (cells µl-1) Exercise 160 248* 176 339 133 163 215
(77-351) (142-435) (111-333) (206-404) (76-294) (121-329) (111-317)
Control 215 174 254 305 185 182 157
(82-317) (83-249) (86-336) (102-456) (4-402) (67-384) (82-246)
CD8+CD11b+ (%) Exercise 9 12* 10 14 8 9 11
(3-19) (7-21) (8-15) (9-16) (4-15) (7-17) (6-16)
Control 8 7 8 11 8 7 7
(3-13) (3-11) (2-16) (4-18) (-1 to 22) (4-16) (4-10)
CD8+CD62L+ (cells µl-1) Exercise 386 365 367 481* 373 349 357
(312-440) (275-544) (269-540) (349-631) (238-487) (295-478) (307-492)
Control 408 384 324 445 340 473 363
(161-785) (185-677) (202-467) (157-733) (95-622) (218-620) (125-608)
CD8+CD62L+ (%) Exercise 19 19 17 22* 18 20 20
(16-22) (15-22) (15-21) (17-24) (14-22) (16-20) (16-24)
Control 17 18 13 18 18 18 17
(11-22) (13-22) (7-22) (12-23) (11-25) (14-21) (8-24)
Proportion of CD4+ of
all CD62L+ (%)
Exercise 83 83 76 86*dagger 76 85 83
(69-88) (73-87) (66-83) (78-90) (71-85) (78-89) (77-88)
Control 71 68 73 80 80 77 73
(59-85) (53-81) (56-85) (64-86) (70-89) (68-90) (67-83)
Proportion of CD8+ of
all CD62L+ (%)
Exercise 46 47 53 55* 49 64* 60*
(40-56) (43-60) (43-64) (51-64) (42-58) (49-70) (48-69)
Control 49 44 40 52 53 46 41
(27-64) (26-65) (18-66) (33-63) (20-79) (35-65) (27-66)
CD20+ (cells µl-1) Exercise 161dagger 174dagger 236* 208 171 166 190
(125-223) (144-196) (181-270) (152-261) (156-203) (133-199) (98-283)
Control 289 211 258 226 177 267 269
(184-354) (164-303) (141-395) (176-305) (98-265) (147-332) (212-398)
CD20+ (%) Exercise 8 8 11* 9 9 9 8
(7-10) (6-10) (8-13) (7-11) (7-13) (7-11) (6-13)
Control 12 12 12 12 10 12 14
(5-16) (6-15) (6-17) (6-16) (2-19) (6-17) (11-16)
CD20+CD23+ (cells µl-1) Exercise 97 98dagger 142 138 104 95 95
(69-127) (72-123) (105-167) (90-165) (70-125) (51-125) (48-159)
Control 161 145 148 139 95 154 178
(89-193) (105-157) (98-203) (121-161) (58-157) (93-187) (129-220)
CD20+CD23+ (%) Exercise 5 5 7* 5 5 5 5
(4-6) (4-6) (5-7) (4-7) (3-6) (3-7) 3-7)
Control 6 6 6 6 6 8 8
(3-9) (3-9) (3-10) (3-10) (1-11) (3-10) (6-10)
CD56+CD16+CD57+CD3-
(cells µl-1)
Exercise 190 210*dagger 155 221 109dagger 211 192
(111-230) (167-277) (110-192) (117-317) (80-161) (140-243) (75-278)
Control 173 102*‡ 133 182 206) 151 154
(113-215) (50-198) (78-260) (52-376) (79-345) (100-276) (18-320)
CD56+CD16+CD57+CD3-
(%)
Exercise 10 11‡ 8 9 7‡ 10 9
(6-11) (8-14) (5-11) (6-13) (4-9) (8-13) (4-13)
Control 8 6‡ 6 9 13‡ 7 8
(3-10) (2-9) (2-13) (2-17) (3-22) (2-16) (0-16)
CD56+CD16+CD57-CD3-
(cells µl-1)
Exercise 136 155*‡ 128 155* 115 150 159
(61-256) (86-304) (87-214) (56-372) (84-136) (105-227) (62-283)
Control 104 82*‡ 92 105 134 130 131
(55-188) (36-162) (54-183) (45-263) (73-209) (102-151) (42-205)
CD56+CD16+CD57-CD3-
(%)
Exercise 7 8*dagger 7 7 5* 7 8
(4-11) (5-15) (4-11) (4-15) (3-9) (5-13) (3-13)
Control 5 4‡ 5 6 8 6 7
(2-8) (2-7) (2-8) (2-12) (3-13) (3-9) (1-10)
Monocytes
CD14+ (cells µl-1) Exercise 468 534* 660* 538* 413 599* 605
(279-528) (321-630) (424-1136) (344-643) (334-465) (482-786) (429-665)
Control 603 529 641 780 418 592 518
(203-790) (202-725) (286-770) (258-998) (161-753) (390-666) (276-770)
CD14+ (%) Exercise 97 94 98 98 97 98* 98
(95-98) (91-97) (95-99) (95-99) (94-99) (97-99) (96-99)
Control 95 98 97 98 98 99* 99
(92-99) (96-99) (95-98) (95-99) (96-98) (96-99) (98-99)
CD14+DR+ (cells µl-1) Exercise 421 504* 553* 338 360 494* 451
(257-487) (300-586) (338-1026) (236-488) (294-430) (376-696) (356-583)
Control 567 465 571 627 350 422 433
(203-717) (192-659) (279-688) (242-817) (108-652) (328-556) (270-647)
CD14+DR+ (%) Exercise 88 89 84* 73* 88* 84 89
(85-93) (82-94) (72-91) (56-84) (82-92) (73-91) (74-94)
Control 90 91 90 82 78 86 89
(84-95) (85-96) (84-95) (77-90) (65-94) (72-93) (76-99)
CD62L+CD4+ (cells µl-1) Exercise 424 501* 631* 534* 355 569* 544
(242-500) (284-621) (366-1092) (304-637) (193-434) (338-761) (306-623)
Control 323 320 393 731 407 571 475
(112-626) (155-527) (255-612) (250-900) (100-752) (363-655) (276-680)
CD62L+CD4+ (%) Exercise 90 89 93 95dagger 82* 96 91
(64-102) (62-103) (61-104) (66-107) (48-98) (60-104) (61-105)
Control 82 86 93 91 94 96 91
(44-105) (49-106) (62-102) (64-94) (67-110) (90-98) (86-96)
CD62L+CD4- (cells µl-1) Exercise 4 5 16*dagger 8 10* 8 5
(1-14) (-3 to 32) (1-47) (3-16) (-11 to 69) (-3 to 32) (2-10)
Control 9 5 2 13 10 5 20
(-3 to 33) (0-16) (-1 to 10) (-10 to 52) (0-19) (-1 to 20) (-9 to 53)
CD62L+CD4- (%) Exercise 2 1 2* 1 2 1 1
(0-4) (0-6) (0-9) (-2 to 9) (1-5) (-1 to 7) (0-2)
Control 3 1 1 2 2 1 1
(0-5) (0-3) (0-2) (0-8) (0-4) (-1 to 5) (-1 to 5)
Prop CD14+ of all DR+ (%) Exercise 91 93 86* 74*dagger 89* 85* 92
(89-95) (89-97) (75-93) (59-86) (85-95) (74-92) (76-97)
Control 95 93 93 84 81 88 90
(89-99) (88-98) (88-97) (78-94) (68-97) (73-96) (77-101)
Exercise, n = 7; control, n = 5. LPK, leukocyte plasma concentration. Data are median values with 95 % confidence intervals in parentheses; * P < 0·05 compared to rest (Wilcoxon signed rank test); dagger P < 0·05 compared to control (Mann-Whitney test); ‡ P < 0·01 between change from rest in exercise compared to control group (Mann-Whitney test); § n = 4 due to missing value.

Neutrophils

Compared to rest, neutrophil number increased similarly in both groups (Table 3), peaking in the third blood sample, collected 6 h after exercise. In the exercise group, the neutrophil number at 6 h correlated to the expression of CD4 on CD62L- monocytes at rest (r2 = 0·78, P = 0·002) but not to catecholamines or cortisol in the same sample. The post-exercise adrenaline concentration correlated to neutrophil numbers at 6 h (r2 = 0·84, P = 0·022). In the control group, the neutrophil number at 6 h correlated to both resting plasma concentration of noradrenaline (r2 = 0·96, P = 0·003) and the changes in noradrenaline from the first to second sampling times (r2 = 0·97, P = 0·001).

Lymphocytes

Lymphocyte numbers increased, and peaked at 24 h in the exercise group, but decreased to a minimum at the same time in the control group (Table 3). In both groups, however, the lymphocyte number in sample 4 (at 24 h) was correlated to the T (CD3+) cell number at rest (exercise group: r2 = 0·97, P = 0·0003; control group: r2= 0·90, P = 0·0085). The change in lymphocyte number from rest to 24 h post exercise related to the pre- to post-exercise changes in adrenaline (r2 = 0·96, P = 0·0005). As seen in Table 3 and Table 4, the T and B cell populations seemed to be more affected in the exercise group than in the control group, with changes in absolute numbers, percentage and cell surface receptor density (MFI). Although several values changed compared to rest, few were significantly different from the control group (Table 3 and Table 4).

Table 4. Significantly changed mean fluorescence intensity (MFI) on circulating lymphocytes and monocytes before and after eccentric exercise

Antigen Rest Post 6 h 24 h 48 h 4 days 7 days
Lym CD20 sub CD5- Exercise 602 599 584* 540* 555* 510* 547*
(573-630) (568-629) (543-613) (502-579) (536-583) (498-545) (505-582)
Control 571) 583 563 541 517 530 511
(553-601) (549-599) (550-584) (521-557) (461-591) (215-706) (487-540)
Lym CD4 sub CD3+ Exercise 810dagger 811dagger 806dagger 812dagger 796 801 795
(764-834) (807-819) (796-816) (803-820) (791-805) (793-806) (748-795)
Control 799 796 791 790 796 802 791
(790-803) (787-804) (788-798) (778-798) (770-816) (791-808) (782-803)
Lym CD45 sub DR+ Exercise 708 694 699 703 703* 701 698
(692-717) (679-715) (692-712) (689-717) (679-714) (691-710) (682-708)
Control 708 713 709 700* 704 701 691
(693-726) (693-723) (693-725) (686-713) (688-718) (692-712) (673-711)
Lym CD8 sub CD3+ Exercise 625 619* 609 606 599* 597 593*
(573-699) (580-635) (591-629) (578-631) (572-609) (559-615) (535-613)
Control 597 585 583 569 571 582 556
(567-627) (555-622) (546-620) (507-658) (486-651) (519-630) (517-581)
Mon CD11b sub 62L+ Exercise 653 663 700 662 584 701 683
(567-719) (572-723) (595-747) (566-728) (511-659) (611-745) (544-770)
Control 598 578 615 658 701 672* 574
(472-715) (455-729) (483-748) (530-754) (572-794) (656-724) (501-643)
Mon CD14 sub DR+ Exercise 804 801 795* 757* 772* 756* 754
(785-821) (778-818) (770-801) (733-782) (751-796) (717-788) (716-786)
Control 787 781 782 760* 743 744* 751
(763-805) (704-816) (773-800) (734-776) (681-829) (727-764) (692-807)
Mon CD14 sub DR- Exercise 779 755 772 743 747* 740* 733
(752-789) (707-783) (743-789) (726-767) (693-766) (685-767) (697-768)
Control 755 769 750 733* 711 737* 735
(758-791) (701-818) (712-796) (655-784) (645-805) (714-760) (651-815)
Mon CD4 sub CD62L+ Exercise 690 697 631*‡ 615* 705dagger 598* 610*
(669-707) (669-704) (595-661) (589-669) (657-725) (581-646) (577-676)
Control 699 703 683*‡ 654* 583‡ 600* 688
(648-743) (642-743) (622-727) (594-712) (511-701) (585-623) (627-734)
Mon CD4 sub CD62L- Exercise 685 693 617* 641 693dagger 632* 626*
(671-699) (663-717) (588-655) (608-685) (631-727) (571-670) (602-680)
Control 701 697 683 669 616 634 711
(647-735) (639-733) (611-726) (646-699) (576-641) (604-650) (559-801)
Mon CD45 sub CD14+DR+ Exercise 686 679 678 659*‡ 678dagger 657* 659
(668-698) (661-696) (670-686) (628-675) (664-699) (632-686) (663-700)
Control 684 682 685 670‡ 656 668* 674
(670-703) (663-701) (657-712) (651-684) (642-675) (626-685) (630-705)
Mon CD45 sub CD14+DR- Exercise 650dagger 641 660 627* 642 614* 631
(631-665) (606-662) (642-665) (598-644) (611-673) (577-653) (595-667)
Control 668 659 646 631* 616 631 640
(657-681) (647-678) (614-685) (580-670) (599-638) (599-648) (585-689)
Exercise, n = 7; control, n = 5. Data are median values with 95 % confidence intervals in parentheses; dagger P < 0·05 compared to control (Mann-Whitney test); *P < 0·05 compared to rest (Wilcoxon signed rank test); § P < 0·01 between change from rest in exercise compared to control group (Mann-Whitney test). MFI for CD antigen on phenotype subset; for example, Lym CD45 sub DR+ indicates CD45 expression on DR+ lymphocyte.

Monocytes

Blood monocyte number (CD14+ cells) increased in the exercise group only (Table 3), with a first increase from immediately after exercise lasting for 24 h with a peak at 6 h. This increase was related to the oxygen consumption during the eccentric exercise (r2 = 0·92, P = 0·002). A second increase in monocyte number occurred in the sixth blood sample 4 days after exercise. This increase correlated to neutrophil and free testosterone levels at 24 h (r2 = 0·98, P = 0·0002). The number of several monocyte subpopulations increased in samples taken from immediately after, to up to 4 days after exercise, while no changes were seen in the control group (Table 3). Again, few values are significantly different from controls. At the same time, the receptor density of CD4, CD14 and CD45 was down-regulated in both the exercise and control groups (Table 4).

NK cells

Circulating NK (CD56+CD16+CD57-CD3-) cells increased immediately and 24 h after exercise, while the number decreased in the second sample in the control group (Table 3). The median NK cell number was, however, never significantly different between the two groups, even though the change in number differed. The number of the subset of NK cells expressing CD57 (Leu 7), (CD56+CD16+CD57+CD3-) increased after exercise and was significantly higher than in the control group, in which the number actually decreased in the second sample. At 48 h post exercise, the number of CD56+CD16+CD57+CD3- cells was significantly lower in the exercise group than in the control group.

No regression model could be found for the increased NK (CD56+CD16+CD57-CD3-) cell number in the post-exercise blood sample. Increases in adrenaline and noradrenaline did not correlate to the changes. A decrease in CD57- NK cell number between the first and the second blood sample in the control group was positively correlated to CD20 expression on CD5- lymphocytes in the second blood sample (r2 = 0·81, P = 0·024). If the effect of the adrenaline concentration in the second sample was added, the correlation increased (r2 = 0·99, P = 0·007). When exercise and control groups were combined, a weak correlation was found between CD57- NK cells and adrenaline in the second blood sample (r2 = 0·56, P = 0·008).

Changes in CD56+CD16+CD57+CD3- cell numbers after exercise correlated positively to the resting noradrenaline concentration (r2 = 0·71, P = 0·021). The correlation with the increase in adrenaline was weak (r2 = 0·56, P = 0·056), but the combined effect of noradrenaline and adrenaline was positively correlated (r2 = 0·91, P = 0·013). In the control group, the decrease in CD57+ NK cells was not correlated to catecholamines but was negatively correlated to the change in proportion of CD14+ monocytes of all DR+ monocytes between the first and the second sample (r2 = 0·97, P = 0·001).

Also of some interest is the finding that the change in CD57+ NK cells due to exercise was positively correlated to the subjects' O2,max (r2 = 0·63, P = 0·021), while the change in CD57- NK cells was not (r2 = 0·08, P = 0·53).

Thus, distinct subpopulations of NK cells respond somewhat differently in response to eccentric exercise and/or multiple muscle biopsies. CD57+ NK cells appear to be more affected by catecholamines and more related to physical exercise than CD57- NK cells.

Antigen expression in muscle

All antigens investigated, except CD79alpha (B cell marker) were detected to some extent in all muscle sections analysed (Table 5). The main antigens detected were, however, markers for leukocytes/neutrophils (CD11b and CD15), macrophages (CD163), activated satellite cells (CD56) and IL-1alpha and IL-1beta.

Table 5. Expression of leukocyte and cytokine antigens in human skeletal muscle after eccentric (percentage of stained area of total muscle section area analysed)

Antigen Rest Post 6 h 24 h 48 h 4 days 7 days
CD3 Exercise 0·01 0·02 0·03* 0·03 0·02 0·02 0·01
(0-0·1) (-0·02 to 0·09) (-0·01 to 0·11) (-0·01 to 0·12) (0·01- 0·04) (0-0·10) (0-0·04)
Control 0·03 0·01 0·02 0·03 0·02 0·03 0·02
(0·01-0·04) (0-0·03) (-0·02 to 0·06) (-0·01 to 0·08) (-0·01 to 0·07) (-0·05 to 0·19) (-0·02 to 0·07)
CD4 Exercise 0·01 0·01 0·02dagger 0·03 0·05 0·04 0·03
(-0·01 to 0·08) (-0·04 to 0·15) (0-0·09) (0-0·08) (0-0·18) (0·02-0·06) (-0·01 to 0·13)
Control 0·01 0·01 0·01 0·02 0·01 0·04* 0·29
(0-0·01) (-0·01 to 0·04) (0-0·01) (-0·05 to 0·16) (-0·09 to 0·24) (-0·08 to 0·39) (-0·21 to 0·80)
CD8 Exercise 0·01 0·01 0·02dagger 0·03 0·01 0 0·02
(-0·01 to 0·06) (-0·01 to 0·06) (-0·02 to 0·12) (0·0-0·05) (-0·02 to 0·08) (-0·01 to 0·07) (0-0·04)
Control 0·01 0·01 0 0·01 0·01 0·01 0·01
(0-0·02) (0-0·02) (0-0·01) (-0·01 to 0·05) (-0·01 to 0·03) (0-0·02) (0-0·02)
CD11b Exercise 0·02 0·04 0·06 0·24* 0·32* 0·06* 0·03
(0-0·10) (-0·02 to 0·20) (-0·01 to 0·29) (0·02-0·67) (0·07-0·70) (0·02-0·22) (-0·01 to 0·22)
Control 0·02 0·06 0·05 0·16* 0·11 0·05* 0·04
(0-0·07) (-0·27 to 0·72) (0·01 to 0·08) (-0·02 to 0·49) (-0·03 to 0·25) (-0·24 to 0·75) (-0·28 to 0·64)
CD15 Exercise 0·03 0·03 0·04dagger 0·08 0·13 0·01 0·02dagger
(-0·02 to 0·12) (0-0·12) (-0·05 to 0·24) (-0·12 to 0·61) (-0·03 to 0·60) (-0·02 to 0·08) (0·01-0·02)
Control 0 0·01 0·01 0·02 0·02* 0·02 0·15
(0-0·01) (-0·39 to 0·86) (0-0·02) (-0·09 to 0·30) (-0·01 to 0·10) (-0·06 to 0·27) (-0·03 to 0·15)
CD56 Exercise 0·07 0·03dagger 0·01 0·03 0·08 0·01 0·03
(0·03-0·13) (-0·04 to 0·17) (-0·03 to 0·17) (0-0·08) (-0·24 to 0·86) (0-0·10) (0·01-0·13)
Control 0·01 0·05 0·05 0·05 0·03 0·07 0·02
(0-0·13) (0·03-0·11) (-0·03 to 0·15) (-0·08 to 0·29) (0·01 to 0·07) (-0·15 to 0·55) (-0·08 to 0·21)
CD79a Exercise 0 0 0 0 0·01 0 0
(-0·03 to 0·08) (0-0·01) (0-0·01) (0-0·01) (-0·03 to 0·09) (-0·03 to 0·08) (-0·01 to 0·02)
Control 0·01 0·01 0 0 0* 0·01 0
(0-0·01) (0-0·01) (0-0·01) (-0·01 to 0·04) (0-0) (0-0·01) (0-0·02)
CD163 Exercise 0·01 0·02 0·03 0·09 0·15* 0·04 0·03
(0-0·09) (0-0·06) (0·01-0·09) (0·02-0·19) (0·03-0·29) (0·01-0·17) (0·01-0·09)
Control 0·01 0·01 0·03 0·03 0·01 0·17* 0·68
(0-0·03) (0-0·03) (0-0·06) (-0·02 to 0·18) (-0·08 to 0·28) (-0·07 to 0·58) (-0·84 to 2·66)
CD56 on muscle
cells (% stained
fibres)
Exercise 0 0·27 1·63* 1·39* 2·71* 0·82 1·81
(-0·15 to 0·69) (-0·06 to 1·24) (0·36-2·65) (0·33-3·07) (0·12-10·28) (0·07-1·73) (-0·77 to 6·53)
Control 0 0 0 2·02* 0·72 1·36 0·48
(-0·33 to 0·70) (-0·44 to 0·94) (-1·11 to 3·35) (0·08-3·90) (-3·37 to 9·44) (0·25-2·50) (-0·08 to 0·86)
IL-1alpha Exercise 0·86 1·03 1·31 0·86 1·66 1·32 0·22
(-10·5 to 5·90) (-0·62 to 7·19) (-0·21 to 6·96) (0·23 to 1·92) (-3·89 to 13·8) (-3·54 to 14·2) (-0·05 to 1·29)
Control 1·49 1·90* 2·31* 1·59 3·09 1·73 0·68
(0·07-2·53) (-3·23 to 11·2) (0·45-4·03) (0·29-3·64) (0·79-4·37) (0·79-2·26) (-2·08 to 6·33)
IL-1beta Exercise 1·20 1·95* 1·65* 2·00 0·96 1·42 1·42
(0·55-1·96) (0·82-3·57) (1·07-3·29) (-0·18 to 6·41) (0·07-2·56) (-0·47 to 6·13) (0·89-3·12)
Control 1·10 1·89* 3·72 2·46 2·12 1·90 1·42
(-1·36 to 6·26) (-0·48 to 7·53) (-0·10 to 6·28) (-0·07 to 6·57) (0·36-4·64) (0·85-3·80) (0·27-3·81)
Exercise, n = 7; control, n = 5. Data are median values with 95 % confidence intervals in parentheses; dagger P < 0·05 compared to control (Mann-Whitney test); * P < 0·05 compared to rest (Wilcoxon signed rank test).

T (CD3, CD4 and CD8) and B (CD79alpha) cells were scarce in healthy human skeletal muscle tissue, both at rest and after exercise and/or multiple biopsies.

Leukocytes/neutrophils (CD11b/CD15)

CD11b, the complement 3bi receptor, was detected on between 0·02 and 1·2 % (mininimum and maximum) of the total section area. The increase in CD11b detection was significant, compared to rest, at 24 h, 48 h and 4 days post exercise. A similar increase occurred in the control group (biopsies only; Table 5) and the change in the exercise group was therefore never significantly different from control. In the exercise group, detection of CD11b peaked at 24 h post exercise and correlated positively to eccentric O2 (l min-1) and negatively to the testosterone/cortisol ratio post exercise (r2 = 0·97, P = 0·003). Increased CD11b detection in the control group also peaked at 24 h, but correlated to resting NK (CD56+CD16+CD57-CD3-) cell number (r2 = 0·99, P = 0·0005). CD15 displayed a similar pattern as CD11b, with a detected staining between 0 and 1·3 % of total section area (Table 5).

Activated satellite cells (CD56)

Antibodies to CD56 stained between 0 and 1·9 % (minimum and maximum) of the total muscle section area. Most of the staining was located on the membrane of small muscle cells, or cells of polygonal shapes (Fig. 1). These cells are believed to be activated satellite cells or myoblasts (Illa et al. 1992) and are therefore a sign of regenerating muscle fibres. Very few non-muscle cells (e.g. potential NK or neuroectodermal cells) expressing CD56 were observed. As with CD11b, the proportion of CD56+ muscle cells (of all muscle cells) increased in both the exercise and control group, with a peak at 24 h in control, and at 48 h in exercise subjects (Table 5).

Macrophages (CD163)

Detection of the macrophage-specific antigen CD163 revealed that between 0 and 2·3 % (minimum and maximum) of the total muscle section area consisted of macrophages. The percentage of stained area increased similarly in both the exercise and control group, with peaks at 48 h and 4 days, respectively. The largest area of macrophages staining positive was seen in the 6th biopsy (taken at 4 days) from two control subjects. Macrophages were located at the edge in both biopsies, suggesting that the previous biopsy from the same leg (the 4th biopsy taken at 24 h) had a direct effect on the tissue obtained in the 6th biopsy (Fig. 2).

View larger version
[in this window]
[in a new window]

    Figure 2

    Infiltration of macrophages in human muscle tissue, located at the periphery of the biopsy.

IL-1alpha

Intracellular interleukin-1alpha (IL-1alpha) was detected in most muscle sections (0-8·1 % of section area), but changed compared to rest in the control group only, with the median peak increase 6 h after the first biopsy (Table 5). IL-1alpha detection was located in both muscle and non-muscle cells, endothelial cells being a likely non-muscle cell source when comparing IL-1alpha and EN-4 (endothelium) staining patterns.

IL-1beta

Almost all muscle sections contained intracellular IL-1beta (Table 5 and Fig. 3). IL-1beta was located in both muscle and non-muscle cells.

View larger version
[in this window]
[in a new window]

    Figure 3

    Staining of IL-1beta in human skeletal muscle. IL-1beta appears located in muscle cells (A) and non-muscle cells (B).

IL-1ra and TNFalpha

These antigens were not detectable in any of the 90 biopsies analysed.

IL-6

Biopsies from two exercised subjects and one control subject were stained with two different IL-6 antibodies, one rat monoclonal and one goat polyclonal (Table 2). The goat polyclonal IL-6 antibody gave an even background stain in all sections, while the rat monoclonal IL-6 antibody resulted in a few distinctly stained areas (Fig. 4). IL-6 was found in low levels (0-0·02 % of section area; data not shown) within both muscle and non-muscle cells and was only changed in the 7th biopsy from the control subject (0·045 %).

View larger version
[in this window]
[in a new window]

    Figure 4

    IL-6 expression in human skeletal muscle cells (A).

  DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

The present study investigated immunological variables in blood and muscle tissue before and after strenuous eccentric cycling exercise together with multiple biopsies or multiple biopsies only. The results clearly demonstrate that with respect to infiltrating neutrophils and macrophages, satellite cell activation and IL-1beta detection, eccentric cycling exercise and multiple biopsies cause similar changes in adult human skeletal muscle (Table 4, Table 5 and Table 6). T and B cell antigens were only detected in minute quantities in muscle tissue samples (Table 5). In the blood, eccentric cycling exercise resulted in significantly larger changes than multiple biopsies, although multiple biopsies also induced changes in some blood leukocyte phenotypes and hormones (Table 3, Table 4, Table 5 and Table 7). In both groups, immunological changes in muscle (i.e. a 12-fold increase in CD11b) were vastly larger than leukocyte changes in blood (usually less than 2-fold). Individual changes varied significantly (large confidence intervals; Table 3, Table 4 and Table 5). This could be explained by the fact that the cells of the immune system have memory and undergo somatic mutation. The response to identical stress events can therefore differ from one time point to another, even in the same individual. In some cases, similar immunological changes in exercised and non-exercised muscle related to different causal mechanisms (Fig 5, Fig 6, Fig 7, Fig 8, Fig 9 and Fig 10). Thus, even if eccentric cycling exercise induces immunological changes in human skeletal muscle, the exercise-induced changes are inferior to the changes inflicted by the biopsy procedure itself.

Table 6. DOMS, CK and CRP after eccentric exercise

Variable Time after work
Rest Post 6 h 24 h 48 h 4 days 7 days
DOMS (0-10) Exercise 0 0 2·5 6·0 5·5 3·0 0
    (0·8-4·2) (4·1-7·2) (1·7-5·7) (1·8-4·8) (-0·7 to 2·7)
Control 0 0 0 0 0 0 0
CK (U l-1) Exercise 53·5 60·5* 119·0* 119·5* 84·2* 61·5dagger 68·0
(42·0-70·3) (47·2-81·2) (22·8-310·0) (51·1-258·9) (62·0-129·9) (49·8-79·6) (36·0-132·6)
Control 247·0 241·0 241·0 179·0 134·9 121·7 86·2
(30·8-347·6) (29·1-347·2) (56·5-369·8) (77·3-344·9) (45·9-382·1) (44·9-269·1) (39·0-142·3)
CRP (µg ml-1) Exercise 0·25 0·28 0·25 1·23 0·82 0·63 0·38
(0·11-0·58) (0·11-0·61) (-8·55 to 20·6) (0·58-1·78) (0·44-1·30) (-7·11 to 18·9) (-1·70 to 5·68)
Control 0·37 0·37 0·38 0·64 0·55 0·57 0·35
(0·25-0·75) (0·24-0·75) (0·24-0·74) (0·40-0·74) (-0·15 to 2·14) (-0·28 to 2·04) (-0·27 to 1·40)
Exercise, n = 7; control, n = 5. Median (95 % confidence interval); dagger P < 0·05 compared to control (Mann-Whitney test); * P < 0·05 compared to rest (Wilcoxon signed rank test).

Table 7. Hormone response to eccentric cycling exercise

Hormone (nmol l-1) Time after work
Rest Post 6 h 24 h 48 h 4 days 7 days
Adrenaline Exercise 0·28 0·63*dagger - - - - -
(0·13-0·38) (0·33-1·00)
Control 0·018 0·17 - - - - -
(0·09-0·29) (0·02-0·43)
Noradrenaline Exercise 2·11 5·24*dagger - - - - -
(1·34-3·16) (3·46-6·53)
Control 2·09 2·13 - - - - -
(1·26-3·06) (1·24-3·24)
Dopamine Exercise 0·10 0·23 - - - - -
(0-0·33) (0·12-0·34)
Control 0·17 0·16 - - - - -
(0·07-0·30) (0·03-0·37)
Cortisol Exercise 379 369 221 412 372 357 421
(195-501) (224-461) (86·6-380) (388-445) (302-427) (332-431) (370-482)
Control 404 321* 236*361 293 348 327  
(225-482) (90·3-435) (39·7-379) (238-497) (178-444) (234-455) (184-533)
Free testosterone Exercise 10·9 12·0 8·40 11·7 11·9 11·9 13·0
(5·88-13·99) (11·0-13·8) (5·44-10·1) (8·35-17·7) (10·2-12·6) (10·2-13·0) (11·5-15·3)
Control 12·6 13·3 10·8 14·4 12·3 12·3 12·7
(8·78-16·6) (6·47-16·4) (6·05-14·1) (11·2-17·7) (9·59-15·3) (9·69-14·3) (8·52-17·3)
Total testosterone Exercise 19·4 20·2 14·6 22·26 19·5 19·6 24·1*
(10·3-23·6) (18·5-23·6) (16·1-27·2) (8·56-23·6) (16·7-23·2) (17·1-22·9) (19·0-26·0)
Control 22·8 22·4 18·7* 23·4 21·5 20·2 22·3
(15·8-28·3) (12·4-28·2) (11·7-24·0) (20·6-29·8) (17·5-27·3) (17·5-25·8) (14·0-31·3)
Exercise, n = 7; control, n = 5. Median (95 % confidence interval); dagger P < 0·05 compared to control (Mann-Whitney test); * P < 0·05 compared to rest (Wilcoxon signed rank test).

Previous publications have indicated that biopsies affect adjacent muscle fibres and serum enzymes (Aronson et al. 1998). Few investigators of exercise-induced changes in human muscle have considered these results in their study design. Conclusions regarding exercise-induced damage, leukocyte infiltration and inflammation in human muscle tissue based on results from studies with multiple muscle biopsies should therefore be reconsidered (Friden et al. 1983; Cannon et al. 1989; Smith, 1991; Friden & Lieber, 1992; Fielding et al. 1993; Hellsten et al. 1997).

It has been suggested that DOMS could be caused by acute inflammation (Smith, 1991; MacIntyre et al. 1995). However, human studies where exercise-induced muscle damage has been directly measured are few and some of the often cited original investigations were performed either on electrically stimulated (Lieber et al. 1996) or on exercised (Armstrong et al. 1983) animal muscle and lack statistical comparison with non-exercised control muscle (Friden et al. 1983; Fielding et al. 1993) or both (Kuipers, 1994).

A temporal association between infiltration of neutrophils, macrophages, satellite cell activation and DOMS was observed in the present study (Table 5 and Table 6). Because immunological changes in muscle were similar in the exercise and control groups, and no statistical correlation was found between DOMS and immunohistochemical analyses or inflammation markers in blood (CRP, T and B cells, neutrophils, monocytes), it can be concluded that DOMS in men is not caused by cellular or humoral inflammation. The present results obtained with different staining procedures (including Gomori trichrome, acid phosphatase and desmin) challenge the notion that eccentric cycling exercise causes significant cytoskeletal disruption and inflammation in human skeletal muscle. In contrast to the conclusion reached by others (Shek & Shephard, 1998), the lack of significant exercise-induced inflammation in the present study excludes eccentric cycling as a good model for studying muscular inflammatory diseases in human.

No correlations between CK activity in blood and leukocyte phenotypes in blood or muscle were found at any time point. The peak CK activity at 24 h post exercise was, however, correlated to the combined effect of cortisol and testosterone. This observation supports the opinion that CK is not a reliable marker of exercise-induced muscle damage (Kuipers, 1994; Warren et al. 1999). Instead, it supports observations that CK activity in blood may be linked to sex hormones because CK usually increases more in males than females in response to similar physical activity (Evans & Cannon, 1991; Kuipers, 1994). In one of the few studies where actual muscle damage and CK were measured, Fielding et al. (1993) found no correlation between z-band damage and CK activity in serum (for review see Warren et al. (1999)). If we accept the argument that CK activity in venous or capillary blood is not a relevant marker of muscle damage, conclusions made in studies (including our own observations: Malm et al. 1999) of 'exercise-induced muscle damage', where CK is the only indicator of muscle damage, should be re-evaluated. Because the expression of CK in differentiating satellite cells increases (Grounds, 1991), and the peak increase in serum CK occurs at the same time as peak CD56 expression in muscle (Table 5 and Table 6), it is suggested, but not proven, that serum CK is more related to exercise-induced muscle adaptation than damage.

Due to the complexity of the human immune system, investigations of immunological events in humans demand elaborate models. At present, use of the intact organism is inevitable because it is the only model that contains all variables, known and unknown. Because of the synergism and antagonism within the immune system, exclusion of one or more factors renders the functional outcome unpredictable. Consequently, results from in vitro and animal models are important for understanding single events, but have limited validity when describing the effects of voluntary physical exercise on the human immune system and muscle tissue (Grounds, 1991). In an attempt to describe the interactions between local and systemic events, multiple regression analysis was used to find likely causes of changed immunoreactivity in the analysed muscle samples (Fig 5, Fig 6, Fig 7, Fig 8, Fig 9 and Fig 10).

Identical changes in CD11b detection in the exercised and control groups (Fig. 5) correlated to resting numbers of circulating NK cells (CD56+CD16+CD57-CD3-) in the control group. A combination of eccentric O2 and the testosterone/cortisol quota (an indicator of metabolic stress) was responsible for changes in the exercise group. A direct link between circulating NK cells and neutrophil infiltration in damage muscle has not been reported. Not all functions of the NK cell are known and, as stated by Tidball (1995), 'non-muscle cells may play a complex and essential role in regulating the muscle repair process'. Mechanically damaged muscle fibres require circulating leukocytes for repair (Robertson et al. 1992) and NK cells may thus have a regulatory function in muscle repair. Physical exercise and a decreased testosterone/cortisol quota (increased physical stress), resulting in increased accumulation of neutrophils in muscle tissue in the exercised group, are in agreement with previous investigations of neutrophil accumulation in muscle tissue after downhill running (Fielding et al. 1993). Neutrophils are known to induce tissue destruction (Dallegri & Ottonello, 1997), but also to release factors necessary for repair and immunomodulation (Pyne, 1994). In the study by Fielding et al. (1993), neutrophil accumulation was related to z-band damage. Contrary to the findings by Fielding et al., we did not find a correlation between neutrophil and IL-1beta in muscle (r < 0·4, P > 0·25 at all times, Spearman rank test). The correlation in the study by Fielding et al. (1993) was, however weak (r = 0·36, P < 0·06, Spearman rank test). The detected increase in CD11b can have different effects depending on the cells bearing the molecule. As identification of the different leukocyte subsets expressing CD11b in muscle tissue was not done, our study cannot address this issue.

View larger version
[in this window]
[in a new window]